These pinhole glasses cost about the same as a pair of sunglasses at the grocery store, and they’re not medical devices at all, so they need no prescription. They contain no lenses, either. Safety note: Do not wear pinhole glasses while driving or operating heavy machinery such as an airplane, an automobile or a wrecking ball crane. These glasses partially obscure vision and should be used solely as exercise devices in a safe environment like your home. They don’t work for every case of vision impairment, of course, as there are many causes for blurred vision. But they work remarkably well for most people who try them. Many people are absolutely AMAZED at the instant difference they see when putting on these pinhole glasses.
For the original version including any supplementary images or video, visit http://www.naturalnews.com/034345_blurred_vision_eye_doctors_pinhole_glasses.html
Eye Bank to honor David Chu, M.D., as ‘Man of Vision’
His many accomplishments reflect the Eye Banks mission to preserve and restore sight. A graduate of the New York University School of Medicine, Dr. Chu is the founder and director of the Metropolitan Eye Research and Surgery Institute of New York and New Jersey, as well as an associate professor of clinical ophthalmology at the Institute of Ophthalmology and Visual Science, New Jersey Medical School of Rutgers University, in Newark. He serves as Medical Director for the Lions Eye Bank of New Jersey and team ophthalmologist for the New York Jets. He is actively involved in numerous ophthalmology organizations. As the Eye Banks third Man of Vision award recipient, Dr. Chu is in good company fellow ophthalmologists Marco Zarbin, M.D., Ph.D., FACS, and William Constad, M.D., previously received the honor. Retired Jersey City educator, cornea recipient and Eye Bank board member Walter McDermott is leading the events planning committee.
For the original version including any supplementary images or video, visit http://centraljersey.com/articles/2013/08/29/newswire/doc521d05687114e677920599.txt
A black eye for Vision Eye
Debt has been dropping consistently since 2008, and at the end of July 2013, Vision Eye reports that it had just $37 million in net bank debt. Day surgery growth continues, with theatre revenues now accounting for 34% of total group revenue, after rising 6%, reflecting increasing demand for non-discretionary surgical procedures. Surgical revenues rose 5%, consistent with the trend in theatre revenue. Moving to the outlook for the next financial year, Vision Eye says its priority is driving greater utilisation of its day surgeries, and can now consider expanding its footprint ? we assume through acquisitions. Foolish takeaway Despite today?s fall, Vision Eye has outperformed the S&P /ASX Index ( ^AXJO ) (ASX:XJO) over the past year, rising close to 30%, compared to the index return of 20%.
For the original version including any supplementary images or video, visit http://au.finance.yahoo.com/news/black-eye-vision-eye-045942234.html